Press-release for stocks related to ces

Prices are updated after-hours

therapeutics tags : Ces

save search

Freeline Announces $26.1 Million Registered Direct Offering of American Depositary Shares
Published: 2022-03-11 (Crawled : 03:00) - globenewswire.com
FRLN | $6.48 0.0% 0

Health Technology

| 523.08% | O: -0.96% H: 0.0% C: 0.0%
offering america pos ces

Travere Prices Upsized $275 Million Convertible Senior Notes Offering
Published: 2022-03-09 (Crawled : 03:00) - globenewswire.com
TVTX | $5.46 -4.88% -5.13% 2M

Health Technology

| -77.07% | O: -1.56% H: 7.35% C: 7.35%
offering ces

Context Therapeutics® Announces Acceptance of Five Abstracts to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2022
Published: 2022-03-08 (Crawled : 00:00) - globenewswire.com
CNTX | $1.38 -2.13% -2.17% 37K

Health Technology

| -24.2% | O: 3.21% H: 7.21% C: 6.21%
therapeutics america ces research cancer

Enlivex Announces Issuance of Israeli Patent Covering Allocetra Derived from Pooled Donor Cells
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
ENLV | News | $1.52 15.15% 13.16% 130K

Health Technology

| -69.76% | O: -0.6% H: 6.29% C: 2.84%
israel ces patent cel

TG Therapeutics Announces Extension of U.S. FDA BLA/sNDA PDUFA Date for Ublituximab Plus UKONIQ® (U2) to Treat Patients with CLL and SLLFDA sets updated PDUFA goal date of June 25, 2022
Published: 2022-03-03 (Crawled : 13:30) - biospace.com/
TGTX | $13.99 -1.83% -1.86% 2.7M

Health Technology

| 33.4% | O: -0.86% H: 0.0% C: 0.0%
ukoniq fda ces therapeutics pdufa set

Medicenna Announces Appointment of Clinical Advisory Board and Dr. Kapil Dhingra as Strategic Advisor
Published: 2022-03-03 (Crawled : 13:00) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M

Health Technology

| 201.32% | O: 2.08% H: 1.86% C: 1.5%
MDNA | $0.157 -0.32% 1.3M

Health Technology

| -90.19% | O: 1.31% H: 0.0% C: -5.61%
ces

Zai Lab Announces Financial Results and Corporate Updates for Twelve Months Ended December 31, 2021
Published: 2022-03-01 (Crawled : 23:00) - globenewswire.com
ZLAB | $15.66 3.57% 3.45% 430K

Health Technology

| -70.2% | O: -4.85% H: 0.0% C: 0.0%
MRTX | $58.7 -0.17% 0.34% 0

Health Technology

| -33.06% | O: 1.93% H: 1.31% C: -0.47%
KRTX | $329.83 0.0% 1.9M

Health Technology

| 201.9% | O: 1.16% H: 1.34% C: -3.47%
BPMC | $92.31 0.02% 0.02% 560K

Health Technology

| 50.48% | O: 0.54% H: 1.2% C: -0.57%
financial results ces results

Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2021 Financial Results and Recent Corporate Developments
Published: 2022-03-01 (Crawled : 23:00) - globenewswire.com
XNCR | $19.05 3.7% 3.57% 760K

Health Technology

| -38.41% | O: 0.29% H: 2.45% C: 0.61%
SRPT | $124.27 6.11% 5.75% 1.3M

Health Technology

| 63.44% | O: 5.06% H: 4.28% C: -0.39%
financial results ces therapeutics results

Horizon Therapeutics plc Reports Fourth-Quarter 2021 and Full-Year 2021 Financial Results; Announces Full-Year 2022 Guidance
Published: 2022-03-01 (Crawled : 15:00) - biospace.com/
HZNP | $116.3 0.03% 29M

Health Technology

| 27.56% | O: 3.13% H: 0.0% C: 0.0%
financial results ces therapeutics report results

Candel Therapeutics Announces $25 Million Non-dilutive Debt Financing Agreement with Silicon Valley Bank
Published: 2022-03-01 (Crawled : 13:30) - globenewswire.com
CADL | $6.03 2.03% 1.99% 670K

| 46.84% | O: 0.24% H: 8.96% C: -2.66%
ces therapeutics

Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2021 and Highlights Recent Corporate Updates
Published: 2022-02-28 (Crawled : 23:00) - biospace.com/
HRTX M | $2.66 -5.0% -5.26% 2.2M

Health Technology

| -64.9% | O: -1.72% H: 1.89% C: -4.31%
financial results ces therapeutics results

Atossa Therapeutics Announces Year-End 2021 Financial Results and Provides Corporate Update
Published: 2022-02-28 (Crawled : 22:00) - atossatherapeutics.com
ATOS | $1.505 1.01% 1.0% 1.9M

Health Technology

| 20.0% | O: -1.6% H: 2.44% C: -0.81%
financial results ces therapeutics results

Arcturus Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Update and Pipeline Progress
Published: 2022-02-28 (Crawled : 22:00) - biospace.com/
TAK | News | $13.23 -1.12% 0.0% 920K

Health Technology

| -11.51% | O: 0.54% H: 1.66% C: 1.13%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| -7.4% | O: 1.79% H: 0.0% C: 0.0%
ARCT 4 | $27.0 -3.33% -3.44% 270K

Health Technology

| 14.13% | O: -0.93% H: 3.16% C: 2.35%
ces therapeutics

Atara Biotherapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Operational Progress
Published: 2022-02-28 (Crawled : 22:00) - biospace.com/
ATRA | $0.7101 -1.18% -1.2% 700K

Health Technology

| -94.62% | O: -0.61% H: 1.41% C: -1.98%
financial results ces therapeutics results iot

Lyra Therapeutics Announces First Patient Dosed in Pivotal ENLIGHTEN I Clinical Trial of LYR-210 in Chronic Rhinosinusitis Patients
Published: 2022-02-28 (Crawled : 13:30) - biospace.com/
LYRA | $5.23 0.38% 0.38% 120K

Health Technology

| 1.55% | O: -1.94% H: 5.94% C: -3.56%
lyr-210 ces trial therapeutics

The Australian Natural Therapeutics Group Signs a US$7.8M Product Agreement With Clever Leaves to Accelerate Medical Cannabis Access in Australia
Published: 2022-02-28 (Crawled : 13:00) - ir.cleverleaves.com
CLVR | $3.96 2.06% 2.02% 6.1K

| 230.25% | O: 0.84% H: 5.0% C: -2.5%
ces cannabis therapeutics cel australia group

Mersana Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Published: 2022-02-28 (Crawled : 12:00) - biospace.com/
MRSN | $2.89 -9.97% -11.07% 3.2M

Health Technology

| -29.58% | O: -1.47% H: 13.65% C: 8.93%
financial results ces therapeutics results

Cyclerion Announces CY6463 Clinical Pipeline and Corporate Updates
Published: 2022-02-24 (Crawled : 16:20) - ir.cyclerion.com
LLY | News | $732.2 -1.81% 0.18% 2.1M

Health Technology